Product Code: ETC12222021 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Gastric Cancer Drugs Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Gastric Cancer Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 China Gastric Cancer Drugs Market - Industry Life Cycle |
3.4 China Gastric Cancer Drugs Market - Porter's Five Forces |
3.5 China Gastric Cancer Drugs Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 China Gastric Cancer Drugs Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 China Gastric Cancer Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.8 China Gastric Cancer Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 China Gastric Cancer Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Gastric Cancer Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastric cancer in China |
4.2.2 Growing awareness and early diagnosis of gastric cancer |
4.2.3 Advances in medical technology and treatment options for gastric cancer |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in China |
4.3.2 High cost of cancer drugs and treatment |
4.3.3 Limited access to healthcare services in rural areas of China |
5 China Gastric Cancer Drugs Market Trends |
6 China Gastric Cancer Drugs Market, By Types |
6.1 China Gastric Cancer Drugs Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 China Gastric Cancer Drugs Market Revenues & Volume, By Disease Type, 2021 - 2031F |
6.1.3 China Gastric Cancer Drugs Market Revenues & Volume, By Adenocarcinoma, 2021 - 2031F |
6.1.4 China Gastric Cancer Drugs Market Revenues & Volume, By Lymphoma, 2021 - 2031F |
6.1.5 China Gastric Cancer Drugs Market Revenues & Volume, By Gastrointestinal Stromal Tumor, 2021 - 2031F |
6.1.6 China Gastric Cancer Drugs Market Revenues & Volume, By Carcinoid Tumor, 2021 - 2031F |
6.1.7 China Gastric Cancer Drugs Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 China Gastric Cancer Drugs Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 China Gastric Cancer Drugs Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.2.3 China Gastric Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.2.4 China Gastric Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.2.5 China Gastric Cancer Drugs Market Revenues & Volume, By Radiation Therapy and Surgery, 2021 - 2031F |
6.3 China Gastric Cancer Drugs Market, By Drug Class |
6.3.1 Overview and Analysis |
6.3.2 China Gastric Cancer Drugs Market Revenues & Volume, By PD-1/PD-L1 Inhibitors, 2021 - 2031F |
6.3.3 China Gastric Cancer Drugs Market Revenues & Volume, By HER2 Antagonists, 2021 - 2031F |
6.3.4 China Gastric Cancer Drugs Market Revenues & Volume, By VEGFR2 Antagonists, 2021 - 2031F |
6.3.5 China Gastric Cancer Drugs Market Revenues & Volume, By Others, 2021 - 2031F |
6.4 China Gastric Cancer Drugs Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 China Gastric Cancer Drugs Market Revenues & Volume, By Oral, 2021 - 2031F |
6.4.3 China Gastric Cancer Drugs Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.5 China Gastric Cancer Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 China Gastric Cancer Drugs Market Revenues & Volume, By Specialty and Retail Pharmacies, 2021 - 2031F |
6.5.3 China Gastric Cancer Drugs Market Revenues & Volume, By Others, 2021 - 2031F |
6.5.4 China Gastric Cancer Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
7 China Gastric Cancer Drugs Market Import-Export Trade Statistics |
7.1 China Gastric Cancer Drugs Market Export to Major Countries |
7.2 China Gastric Cancer Drugs Market Imports from Major Countries |
8 China Gastric Cancer Drugs Market Key Performance Indicators |
8.1 Patient survival rates post-treatment |
8.2 Adoption rate of innovative treatment options |
8.3 Number of clinical trials for gastric cancer drugs in China |
9 China Gastric Cancer Drugs Market - Opportunity Assessment |
9.1 China Gastric Cancer Drugs Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 China Gastric Cancer Drugs Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 China Gastric Cancer Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.4 China Gastric Cancer Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 China Gastric Cancer Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Gastric Cancer Drugs Market - Competitive Landscape |
10.1 China Gastric Cancer Drugs Market Revenue Share, By Companies, 2024 |
10.2 China Gastric Cancer Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |